ONTOLOGY REPORT - ANNOTATIONS
Term: cetrorelix
Accession: CHEBI:59224
browse the term
Definition: A synthetic ten-membered oligopeptide comprising N-acetyl-3-(naphthalen-2-yl)-D-alanyl, 4-chloro-D-phenylalanyl, 3-(pyridin-3-yl)-D-alanyl, L-seryl, L-tyrosyl, N(5)-carbamoyl-D-ornithyl, L-leucyl, L-arginyl, L-prolyl, and D-alaninamide residues coupled in sequence. A gonadotrophin-releasing hormone (GnRH) antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast.
Synonyms: exact_synonym: N-acetyl-3-(naphthalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-L-tyrosyl-N(5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide
related_synonym: C70H92ClN17O14; CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O; InChI=1S/C70H92ClN17O14/c1-39(2)31-52(61(94)82-51(15-9-28-77-69(73)74)68(101)88-30-10-16-58(88)67(100)79-40(3)59(72)92)83-60(93)50(14-8-29-78-70(75)102)81-63(96)54(34-43-20-25-49(91)26-21-43)86-66(99)57(38-89)87-65(98)56(36-45-11-7-27-76-37-45)85-64(97)55(33-42-18-23-48(71)24-19-42)84-62(95)53(80-41(4)90)35-44-17-22-46-12-5-6-13-47(46)32-44/h5-7,11-13,17-27,32,37,39-40,50-58,89,91H,8-10,14-16,28-31,33-36,38H2,1-4H3,(H2,72,92)(H,79,100)(H,80,90)(H,81,96)(H,82,94)(H,83,93)(H,84,95)(H,85,97)(H,86,99)(H,87,98)(H4,73,74,77)(H3,75,78,102)/t40-,50-,51+,52+,53-,54+,55-,56-,57+,58+/m1/s1; InChIKey=SBNPWPIBESPSIF-MHWMIDJBSA-N; cetrorelixum
xref_casrn: 120287-85-6
xref: Beilstein:5860649 "Beilstein Registry Number"; ChEMBL:774441 "ChEMBL COMPOUND"; ChemIDplus:120287-85-6 "CAS Registry Number"; DrugBank:DB00050 "DrugBank"; KEGG DRUG:D07665 "KEGG DRUG"
xref_mesh: MESH:C062876
xref: Patent:EP299402 "Patent"; Patent:US4800191 "Patent"; Wikipedia:Cetrorelix "Wikipedia"
cetrorelix
G
Apoe
apolipoprotein E
multiple interactions
ISO
7
20,281,593
20,284,515
RGD:6480464
CTD
G
Bax
BCL2-associated X protein
increases expression
EXP
7
52,717,065
52,722,268
RGD:6480464
CTD
G
Bax
BCL2-associated X protein
increases expression
ISO
7
52,717,065
52,722,268
RGD:6480464
CTD
G
Bcl2
B cell leukemia/lymphoma 2
decreases expression
ISO
1
108,434,756
108,610,867
RGD:6480464
CTD
G
Bcl2l1
BCL2-like 1
decreases expression
ISO
2
152,606,404
152,657,418
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
8
47,702,803
47,724,071
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
EXP
8
47,702,803
47,724,071
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
8
47,702,803
47,724,071
RGD:6480464
CTD
G
Casp9
caspase 9
increases activity
EXP
4
141,349,527
141,371,890
RGD:6480464
CTD
G
Casp9
caspase 9
increases activity
ISO
4
141,349,527
141,371,890
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A (P21)
increases expression
ISO
17
29,227,931
29,237,667
RGD:6480464
CTD
G
Chga
chromogranin A
multiple interactions
ISO
12
103,793,179
103,803,237
RGD:6480464
CTD
G
Clcf1
cardiotrophin-like cytokine factor 1
decreases expression
ISO
19
4,214,392
4,222,615
RGD:6480464
CTD
G
Cst9
cystatin 9
multiple interactions
ISO
2
148,660,883
148,664,473
RGD:6480464
CTD
G
Cxcl12
chemokine (C-X-C motif) ligand 12
decreases expression
ISO
6
117,118,553
117,131,386
RGD:6480464
CTD
G
Cyb5
cytochrome b-5
multiple interactions
ISO
18
85,020,806
85,049,255
RGD:6480464
CTD
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
ISO
9
57,862,824
57,874,830
RGD:6480464
CTD
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
multiple interactions
ISO
19
46,741,655
46,747,490
RGD:6480464
CTD
G
Ddr1
discoidin domain receptor family, member 1
multiple interactions
ISO
17
35,818,512
35,841,084
RGD:6480464
CTD
G
Dhcr24
24-dehydrocholesterol reductase
multiple interactions
ISO
4
106,233,643
106,261,718
RGD:6480464
CTD
G
Dpep3
dipeptidase 3
multiple interactions
ISO
8
108,497,420
108,503,319
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily member 6)
increases expression
EXP
19
34,365,149
34,402,260
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily member 6)
increases expression
ISO
19
34,365,149
34,402,260
RGD:6480464
CTD
G
Fshb
follicle stimulating hormone beta
decreases expression
ISO
2
106,896,297
106,899,808
RGD:6480464
CTD
G
Fshb
follicle stimulating hormone beta
decreases expression
ISO
2
106,896,297
106,899,808
RGD:6480464
CTD
G
Gsta2
glutathione S-transferase, alpha 2 (Yc2)
multiple interactions
ISO
9
78,178,827
78,194,952
RGD:6480464
CTD
G
Hcrtr1
hypocretin (orexin) receptor 1
decreases expression
ISO
4
129,807,461
129,816,406
RGD:6480464
CTD
G
Hcrtr2
hypocretin (orexin) receptor 2
decreases expression
ISO
9
76,073,687
76,171,385
RGD:6480464
CTD
G
Hmgcs2
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2
multiple interactions
ISO
3
98,084,354
98,114,661
RGD:6480464
CTD
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
multiple interactions
ISO
10
127,427,992
127,444,564
RGD:6480464
CTD
G
Igf1
insulin-like growth factor 1
decreases expression
ISO
10
87,321,801
87,399,792
RGD:6480464
CTD
G
Il6
interleukin 6
decreases expression
ISO
5
30,339,701
30,346,508
RGD:6480464
CTD
G
Insl3
insulin-like 3
multiple interactions
ISO
8
74,213,151
74,214,474
RGD:6480464
CTD
G
Lhb
luteinizing hormone beta
decreases expression
ISO
7
52,673,729
52,675,734
RGD:6480464
CTD
G
Lhb
luteinizing hormone beta
decreases expression
ISO
7
52,673,729
52,675,734
RGD:6480464
CTD
G
Lhb
luteinizing hormone beta
decreases expression
ISO
7
52,673,729
52,675,734
RGD:6480464
CTD
G
Mapk1
mitogen-activated protein kinase 1
decreases phosphorylation
ISO
16
16,983,475
17,047,546
RGD:6480464
CTD
G
Mapk3
mitogen-activated protein kinase 3
decreases phosphorylation
ISO
7
133,903,140
133,909,330
RGD:6480464
CTD
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
multiple interactions
ISO
19
32,694,495
32,741,677
RGD:6480464
CTD
G
Pgrmc1
progesterone receptor membrane component 1
multiple interactions
ISO
X
34,138,220
34,146,074
RGD:6480464
CTD
G
Prl
prolactin
decreases expression
ISO
13
27,149,439
27,157,073
RGD:6480464
CTD
G
Prok1
prokineticin 1
multiple interactions
ISO
3
107,038,449
107,042,625
RGD:6480464
CTD
G
Prps2
phosphoribosyl pyrophosphate synthetase 2
multiple interactions
ISO
X
163,784,265
163,820,631
RGD:6480464
CTD
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
19
5,637,490
5,648,130
RGD:6480464
CTD
G
Rhob
ras homolog gene family, member B
multiple interactions
ISO
12
8,504,564
8,506,791
RGD:6480464
CTD
G
Sc4mol
sterol-C4-methyl oxidase-like
multiple interactions
ISO
8
67,196,942
67,212,375
RGD:6480464
CTD
G
Star
steroidogenic acute regulatory protein
multiple interactions
ISO
8
26,918,985
26,926,454
RGD:6480464
CTD
G
Stat3
signal transducer and activator of transcription 3
decreases phosphorylation
ISO
11
100,748,124
100,800,825
RGD:6480464
CTD
G
Sycp1
synaptonemal complex protein 1
multiple interactions
ISO
3
102,622,422
102,740,023
RGD:6480464
CTD
G
Taf4b
TAF4B RNA polymerase II, TATA box binding protein (TBP)-associated factor
multiple interactions
ISO
18
14,941,754
15,058,868
RGD:6480464
CTD
G
Tex19.2
testis expressed gene 19.2
multiple interactions
ISO
11
120,977,529
120,979,991
RGD:6480464
CTD
G
Tgfb1
transforming growth factor, beta 1
decreases expression
ISO
7
26,472,021
26,490,015
RGD:6480464
CTD
G
Tnfsf13
tumor necrosis factor (ligand) superfamily, member 13
decreases expression
ISO
11
69,496,079
69,499,056
RGD:6480464
CTD
G
Trp53
transformation related protein 53
increases expression
ISO
11
69,393,861
69,405,375
RGD:6480464
CTD
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
17
46,153,942
46,169,326
RGD:6480464
CTD
G
Wisp2
WNT1 inducible signaling pathway protein 2
multiple interactions
ISO
2
163,646,570
163,658,882
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest